Axel Rosell

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Anna Månberg (Häggmark)

KTH Royal Institute of Technology

SWEDEN

View details

Sebastian Havervall

Karolinska Institutet

SWEDEN

View details

Monika Klimkowska

Karolinska University Hospital

SWEDEN

View details

Jacob Odeberg

KTH Royal Institute of Technology

SWEDEN

View details

Steven Grover

Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Mia Phillipson

Professor

Uppsala Universitet Uppsala biomedicinska centrum

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Axel Rosell

Research Interests

Explore related searches

Contact this professor

Articles (11)

No indication of aberrant neutrophil extracellular trap release in indolent or advanced systemic mastocytosis

Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: A feasibility study based on two VTE cohorts.

Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress.

Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress

Neutrophil extracellular traps and cancer-associated thrombosis

Response by Mackman et al to Letter Regarding Article, “Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality—Brief Report”

Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19

Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report

Prognostic value of circulating markers of neutrophil activation, neutrophil extracellular traps, coagulation and fibrinolysis in patients with terminal cancer

Robust humoral and cellular immune responses and low risk for reinfection at least eight months following asymptomatic to mild COVID-19

Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers

Collaborators (6)

Anna Månberg (Häggmark)

Sebastian Havervall

Monika Klimkowska

Jacob Odeberg

Steven Grover

Mia Phillipson

Make your next move.